SUMATRIPTAN SUCCINATE | N020080 | GLAXOSMITHKLINE
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2013-04-29 | Terminated 2014-05-09 | — | |
Acura Pharmaceuticals Inc. v. Impax Laboratories Inc. 1 patentANDA 204124oxycodone hydrochloride | D. Del. | 2012-10-31 | Terminated 2013-11-13 | — |
| D. Del. | 2012-10-31 | Terminated 2014-08-04 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Attachment 2 - IMITREX- sumatriptan tablet, film coated RE Suitability Petiti... FDA-2023-P-4784 · 7 docket documents Hyman, Phelps & McNamara, P.C. filed a citizen petition regarding IMITREX (sumatriptan tablet, film coated) requesting a determination of suitability, likely under 21 CFR 314.80 or related regulatory provisions governing the appropriateness of the drug product formulation or manufacturing process fo | Suitability | 2023-10-30 | Denied | Hyman, Phelps & McNamara, P.C. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$463.07
per ml
Lowest NADAC/Unit
$437.56
per ml
Brand NDCs
3
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00173073900IMITREX 4 MG/0.5 ML PEN INJECT | $463.07 | ML | Brand | — | 2026-06-17 |
| 00173047900IMITREX 6 MG/0.5 ML PEN INJECT | $462.00 | ML | Brand | $67.23 | 2026-06-17 |
| 00173047800IMITREX 6 MG/0.5 ML CARTRIDGES | $437.56 | ML | Brand | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.